Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€29.51

€29.51

1.620%
0.4712
1.620%
€38.00
 
31.05.24 / Tradegate WKN: 891106 / Symbol: RHHBY / Name: Roche / Stock / Pharmaceuticals / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
The full analysis of the stock Roche Holding AG ADR is only available for our menbers.
Not a member yet? Sign up for free!

Financial data and news for Roche

sharewise wants to provide you with the best news and tools for Roche, so we directly link to the best financial data sources.

News

Why Roche Holdings Stock Popped Today: https://g.foolcdn.com/editorial/images/772667/lady-scientist-in-lab-coat-and-goggles-pours-blue-liquid-from-a-test-tube-into-a-beaker.jpg
Why Roche Holdings Stock Popped Today

Shares of Swiss pharmaceuticals giant Roche Holdings (OTC: RHHBY) stock popped 2.5% in early trading Thursday before giving back about half of its gains.

Roche announced this morning that the U.S

This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know: https://g.foolcdn.com/editorial/images/758429/nvidia-headquarters-with-grey-nvidia-sign-in-front-with-nvidia-logo.png
This Big Pharma Is Teaming Up With Nvidia to Make Drugs With AI. Here's What You Need to Know

In late November, Roche's (OTC: RHHBY) subsidiary Genentech and the chipmaker Nvidia (NASDAQ: NVDA) agreed to collaborate on developing new medicines using artificial intelligence (AI) over the next